Brains from subjects with DLB with a range of AD co-pathology levels, and unaffected controls, were subjected to quantitative immunoblotting for pS106-Rab12 and Rab12 (Supplementary Table 1). The gene discussed is RAB12; the disease is Alzheimer disease.